OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Predictive value of NLR and PLR for immune-related adverse events: a systematic review and meta-analysis
Hongrui Lu, Pengfei Zhu, Ya-Ya Deng, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 5, pp. 1106-1116
Closed Access | Times Cited: 9
Hongrui Lu, Pengfei Zhu, Ya-Ya Deng, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 5, pp. 1106-1116
Closed Access | Times Cited: 9
Showing 9 citing articles:
Systemic and local immunosuppression in glioblastoma and its prognostic significance
Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Association between platelet-to-lymphocyte ratio and immune checkpoint inhibitor-induced thyroid dysfunction
Wang Ai, Huijie Huang, Yangli Chen, et al.
Endocrine (2025)
Closed Access
Wang Ai, Huijie Huang, Yangli Chen, et al.
Endocrine (2025)
Closed Access
Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Xinyu Zhang, Bei Zhang, Danfei Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Xinyu Zhang, Bei Zhang, Danfei Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Development and validation of nomogram models for predicting immune-related adverse events in recurrent and metastatic nasopharyngeal carcinoma patients treated with PD-L1 inhibitors
Mengyuan Liu, Zheran Liu, Shuangshuang He, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Mengyuan Liu, Zheran Liu, Shuangshuang He, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Construction and Validation of Risk Prediction Models for Different Subtypes of Retinal Vein Occlusion
Chunlan Liang, Lian Liu, Wenjuan Yu, et al.
Advances in Ophthalmology Practice and Research (2025)
Open Access
Chunlan Liang, Lian Liu, Wenjuan Yu, et al.
Advances in Ophthalmology Practice and Research (2025)
Open Access
Comparison between XGboost model and logistic regression model for predicting sepsis after extremely severe burns
Peng Liu, Xiaojian Li, Tao Zhang, et al.
Journal of International Medical Research (2024) Vol. 52, Iss. 5
Open Access | Times Cited: 2
Peng Liu, Xiaojian Li, Tao Zhang, et al.
Journal of International Medical Research (2024) Vol. 52, Iss. 5
Open Access | Times Cited: 2
Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancer
Akira Sugimoto, Hiroyasu Kaneda, Naoki Yoshimoto, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Akira Sugimoto, Hiroyasu Kaneda, Naoki Yoshimoto, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Inflammatory and nutritional markers in colorectal cancer: Implications for prognosis and treatment
Mesut Tez
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 10, pp. 1264-1268
Closed Access
Mesut Tez
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 10, pp. 1264-1268
Closed Access
Development of a predictive model for immune‑related adverse events in patients with cancer
Yajuan Tang, Jinping Shi, Liping Wang, et al.
Oncology Letters (2024) Vol. 29, Iss. 3
Open Access
Yajuan Tang, Jinping Shi, Liping Wang, et al.
Oncology Letters (2024) Vol. 29, Iss. 3
Open Access
